keyword
https://read.qxmd.com/read/38656706/evaluation-of-chatgpt-and-gemini-large-language-models-for-pharmacometrics-with-nonmem
#1
JOURNAL ARTICLE
Euibeom Shin, Yifan Yu, Robert R Bies, Murali Ramanathan
To assess ChatGPT 4.0 (ChatGPT) and Gemini Ultra 1.0 (Gemini) large language models on NONMEM coding tasks relevant to pharmacometrics and clinical pharmacology. ChatGPT and Gemini were assessed on tasks mimicking real-world applications of NONMEM. The tasks ranged from providing a curriculum for learning NONMEM, an overview of NONMEM code structure to generating code. Prompts in lay language to elicit NONMEM code for a linear pharmacokinetic (PK) model with oral administration and a more complex model with two parallel first-order absorption mechanisms were investigated...
April 24, 2024: Journal of Pharmacokinetics and Pharmacodynamics
https://read.qxmd.com/read/38656678/quantification-of-biochemical-psa-dynamics-after-radioligand-therapy-with-177-lu-lu-psma-i-t-using-a-population-pharmacokinetic-pharmacodynamic-model
#2
JOURNAL ARTICLE
Hinke Siebinga, Berlinda J de Wit-van der Veen, Daphne M V de Vries-Huizing, Wouter V Vogel, Jeroen J M A Hendrikx, Alwin D R Huitema
BACKGROUND: There is an unmet need for prediction of treatment outcome or patient selection for [177 Lu]Lu-PSMA therapy in patients with metastatic castration-resistant prostate cancer (mCRPC). Quantification of the tumor exposure-response relationship is pivotal for further treatment optimization. Therefore, a population pharmacokinetic (PK) model was developed for [177 Lu]Lu-PSMA-I&T using SPECT/CT data and, subsequently, related to prostate-specific antigen (PSA) dynamics after therapy in patients with mCRPC using a pharmacokinetic/pharmacodynamic (PKPD) modelling approach...
April 24, 2024: EJNMMI Physics
https://read.qxmd.com/read/38655842/a-phase-1-clinical-trial-to-assess-the-safety-and-pharmacokinetics-of-a-tenofovir-alafenamide-elvitegravir-insert-administered-rectally-for-hiv-prevention
#3
JOURNAL ARTICLE
Sharon A Riddler, Clifton W Kelly, Craig J Hoesley, Ken S Ho, Jeanna M Piper, Stacey Edick, Faye Heard, Gustavo F Doncel, Sherri Johnson, Peter L Anderson, Rhonda M Brand, Ratiya Pamela Kunjara Na Ayudhya, José A Bauermeister, Sharon L Hillier, Craig W Hendrix
BACKGROUND: On-demand topical products could be an important tool for HIV prevention. We evaluated the safety, pharmacokinetics, and ex vivo pharmacodynamics of a tenofovir alafenamide/elvitegravir (TAF/EVG; 16 mg/20 mg) insert administered rectally. METHODS: MTN-039 was a Phase 1, open-label, single-arm, 2-dose study. Blood, rectal fluid (RF), and rectal tissue (RT) were collected over 72 hours (hr) following rectal administration of one and two TAF/EVG inserts for each participant...
April 24, 2024: Journal of Infectious Diseases
https://read.qxmd.com/read/38655611/pharmacokinetics-and-pharmacodynamics-of-dextroketamine-alone-or-combined-with-midazolam-in-caiman-crocodilus
#4
JOURNAL ARTICLE
Líria Queiroz Luz Hirano, Adrielly Lorena Rodrigues de Oliveira, Rafael Ferraz de Barros, Danillo Fabrini Maciel Costa Veloso, Eliana Martins Lima, André Luiz Quagliatto Santos, Juan Carlos Duque Moreno
Pharmacokinetics studies of anesthetic agents are important for understanding of the pharmacology and metabolism of anesthetic agents in reptilians. This study was designed to examine the pharmacokinetic and pharmacodynamic properties of intravenous dextroketamine alone or combined with midazolam in Caiman crocodilus. Eight caimans were anesthetized with dextroketamine (10 mg/kg; group D) or dextroketamine and midazolam (10 and 0.5 mg/kg respectively; group DM) into the occipital venous sinus...
April 24, 2024: Journal of Veterinary Pharmacology and Therapeutics
https://read.qxmd.com/read/38655598/dihydroergotamine-mesylate-nasal-spray-an-acute-treatment-option-for-migraine-in-adults
#5
REVIEW
Marcello Silvestro, Ilaria Orologio, Alessandro Tessitore, Francesca Trojsi, Gioacchino Tedeschi, Antonio Russo
INTRODUCTION: Although the landscape of migraine symptomatic treatment has been enriched by novel effective drugs, it is mandatory to critically reappraise older molecules to ascertain whether they could still represent reliable alternatives in specific endophenotypes of patients or migraine attacks. Among these, dihydroergotamine (DHE) nasal spray has been shown to be effective and is characterized by greater tolerability and manageability than the parenteral DHE formulation. AREAS COVERED: In this narrative review, the authors describe the pharmacodynamic and pharmacokinetic properties of DHE nasal spray and explore the results of the trials which explored its efficacy, safety and tolerability as migraine symptomatic treatment...
April 24, 2024: Expert Review of Neurotherapeutics
https://read.qxmd.com/read/38654653/the-preclinical-discovery-and-clinical-evaluation-of-tirzepatide-for-the-treatment-of-type-2-diabetes
#6
REVIEW
Ioannis Avgerinos, Panagiota Kakotrichi, Thomas Karagiannis, Eleni Bekiari, Apostolos Tsapas
INTRODUCTION: Despite numerous antidiabetic medications available for the treatment of type 2 diabetes, a substantial percentage of patients fail to achieve optimal glycemic control. Furthermore, the escalating obesity pandemic underscores the urgent need for effective relevant pharmacotherapies. Tirzepatide, a novel dual GIP and GLP-1 receptor agonist, offers a promising therapeutic option. AREAS COVERED: This review describes the discovery and clinical development of tirzepatide...
May 2024: Expert Opinion on Drug Discovery
https://read.qxmd.com/read/38653508/epirubicin-for-the-treatment-of-sepsis-and-septic-shock-epos-1-study-protocol-for-a-randomised-placebo-controlled-phase-iia-dose-escalation-trial
#7
RANDOMIZED CONTROLLED TRIAL
Daniel Thomas-Rüddel, Michael Bauer, Luís Ferreira Moita, Christiane Helbig, Peter Schlattmann, Johannes Ehler, Tim Rahmel, Patrick Meybohm, Matthias Gründling, Heiko Schenk, Thomas Köcher, Frank M Brunkhorst, Markus Gräler, Ann-Julika Heger, Sebastian Weis
INTRODUCTION: Sepsis remains the major cause of death among hospitalised patients in intensive care. While targeting sepsis-causing pathogens with source control or antimicrobials has had a dramatic impact on morbidity and mortality of sepsis patients, this strategy remains insufficient for about one-third of the affected individuals who succumb. Pharmacological targeting of mechanisms that reduce sepsis-defining organ dysfunction may be beneficial. When given at low doses, the anthracycline epirubicin promotes tissue damage control and lessens the severity of sepsis independently of the host-pathogen load by conferring disease tolerance to infection...
April 22, 2024: BMJ Open
https://read.qxmd.com/read/38653502/-physiologically-based-pharmacokinetic-modeling-the-reversible-metabolism-and-tissue-specific-partitioning-of-methylprednisolone-and-methylprednisone-in-rats
#8
JOURNAL ARTICLE
Ruihong Yu, William J Jusko
The pharmacokinetics (PK) of methylprednisolone (MPL) exhibited tissue-specific saturable binding and reversible conversion with its metabolite, methylprednisone (MPN). Blood and 11 tissues were collected in male rats after intravenous (IV) bolus doses of 50 mg/kg MPL and 20 mg/kg MPN and upon IV infusion of MPL and MPN at 0.3, 3, and 10 mg/h/kg. The concentrations of MPL and MPN were simultaneously measured. A comprehensive physiologically based pharmacokinetic (PBPK) model was applied to describe the plasma and tissue profiles and estimate PK parameters of the MPL/MPN interconversion system...
April 23, 2024: Drug Metabolism and Disposition: the Biological Fate of Chemicals
https://read.qxmd.com/read/38653449/early-erythroferrone-levels-can-predict-the-long-term-haemoglobin-responses-to-erythropoiesis-stimulating-agents
#9
JOURNAL ARTICLE
Peng Xu, Raymond S M Wong, Xiaoyu Yan
BACKGROUND AND PURPOSE: Our previous study reported that erythroferrone (ERFE), a newly identified hormone produced by erythroblasts, responded to recombinant human erythropoietin (rHuEPO) sensitively but its dynamics was complicated by double peaks and circadian rhythm. This study intends to elucidate the underlying mechanisms for the double peaks of ERFE dynamics and further determine whether early ERFE measurements can predict haemoglobin responses to rHuEPO. EXPERIMENTAL APPROACH: By using the purified recombinant rat ERFE protein and investigating its deposition in rats, the production of ERFE was deconvoluted...
April 23, 2024: British Journal of Pharmacology
https://read.qxmd.com/read/38653112/engineering-the-protein-corona-strategies-effects-and-future-directions-in-nanoparticle-therapeutics
#10
REVIEW
Tianyu Zhao, Mingli Ren, Jiajie Shi, Haijiao Wang, Jing Bai, Wenli Du, Bai Xiang
Nanoparticles (NPs) serve as versatile delivery systems for anticancer, antibacterial, and antioxidant agents. The manipulation of protein-NP interactions within biological systems is crucial to the application of NPs in drug delivery and cancer nanotherapeutics. The protein corona (PC) that forms on the surface of NPs is the interface between biomacromolecules and NPs and significantly influences their pharmacokinetics and pharmacodynamics. Upon encountering proteins, NPs undergo surface alterations that facilitate their clearance from circulation by the mononuclear phagocytic system (MPS)...
April 22, 2024: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/38652489/synergistically-engineered-nanotransethosomes-for-co-delivery-of-methotrexate-and-baicalin-for-enhanced-transdermal-delivery-against-rheumatoid-arthritis-formulation-characterization-and-invivo-pharmacodynamic-evaluation
#11
JOURNAL ARTICLE
Syeda Nashvia Adin, Isha Gupta, Mohd Aqil, Mohd Mujeeb, Abul Kalam Najmi
Rheumatoid arthritis (RA) is a systemic autoimmune disease that significantly impacts the quality of life of those affected. Owing to the complex pathophysiology of RA, it is not possible for any singular treatment to entirely impede the progression of the disease. Hence, the current study aimed to adopt a holistic and synergistic approach towards the management of RA by means of a co-delivery strategy involving methotrexate (MTH), a conventional slow-acting anti-rheumatic drug, and baicalin (BCN), a bioactive phytochemical using a transethosomal (TRS) gel formulation...
April 23, 2024: Journal of Drug Targeting
https://read.qxmd.com/read/38652112/characterizing-the-nonlinear-pharmacokinetics-and-pharmacodynamics-of-bi-187004-an-11%C3%AE-hydroxysteroid-dehydrogenase-type-1-inhibitor-in-humans-by-a-target-mediated-drug-disposition-model
#12
JOURNAL ARTICLE
Xuanzhen Yuan, Guohua An
BI 187004, a selective small-molecule inhibitor of 11β-hydroxysteroid dehydrogenase-1 (11β-HSD1), displayed complex nonlinear pharmacokinetics (PK) in humans. Following nine single oral doses, BI 187004 exhibited nonlinear PK at low doses and linear PK at higher doses. Notably, substantial hepatic 11β-HSD1 inhibition (50%) was detected in a very low-dose group, achieving a consistent 70% hepatic enzyme inhibition in subsequent ascending doses without any dose-dependent effects. The unusual PK and PD profiles of BI 187004 suggest the presence of pharmacological target-mediated drug disposition (TMDD), arising from the saturable binding of BI 187004 compound to its high-affinity and low-capacity target 11β-HSD1...
April 23, 2024: Journal of Clinical Pharmacology
https://read.qxmd.com/read/38650393/evaluation-of-omadacycline-regimens-for-community-acquired-bacterial-pneumonia-patients-infected-with-staphylococcus-aureus-by-pharmacokinetic-pharmacodynamic-analysis
#13
JOURNAL ARTICLE
Gaoqi Xu, Xin Liu, Jiaqi Wang, Yuqing Mei, Dihong Yang, Chaoneng He, Like Zhong, Junfeng Zhu, Haiying Ding, Luo Fang
Omadacycline is an FDA-approved agent for community-acquired bacterial pneumonia (CABP). The purpose of this study is to evaluate the effectiveness of omadacycline for treating CABP patients infected with Staphylococcus aureus , including Methicillin-Resistant Staphylococcus aureus (MRSA) and Methicillin-Susceptible Staphylococcus aureus (MSSA), using pharmacokinetic/pharmacodynamic (PK/PD) analysis. Monte Carlo simulations (MCSs) were performed by utilizing omadacycline pharmacokinetic (PK) parameters, minimum inhibitory concentration (MIC) data, and in vivo PK/PD targets to calculate the probability of target attainment (PTA) and cumulative fraction of response (CFR) values for different dose regimens against MRSA and MSSA in CABP patients...
April 22, 2024: Journal of Chemotherapy
https://read.qxmd.com/read/38649680/hexahydrocannabinol-hhc-and-%C3%AE-9-tetrahydrocannabinol-%C3%AE-9-thc-driven-activation-of-cannabinoid-receptor-1-results-in-biased-intracellular-signaling
#14
JOURNAL ARTICLE
Oleh Durydivka, Petr Palivec, Matej Gazdarica, Ken Mackie, Jaroslav Blahos, Martin Kuchar
The Cannabis sativa plant has been used for centuries as a recreational drug and more recently in the treatment of patients with neurological or psychiatric disorders. In many instances, treatment goals include relief from posttraumatic disorders, anxiety, or to support treatment of chronic pain. Ligands acting on cannabinoid receptor 1 (CB1R) are also potential targets for the treatment of other health conditions. Using an evidence-based approach, pharmacological investigation of CB1R agonists is timely, with the aim to provide chronically ill patients relief using well-defined and characterized compounds from cannabis...
April 22, 2024: Scientific Reports
https://read.qxmd.com/read/38649307/serum-and-urine-metabolomics-based-on-uplc-qtof-ms-reveal-the-effect-and-potential-mechanism-of-schisandra-evodia-herb-pair-in-the-treatment-of-alzheimer-s-disease
#15
JOURNAL ARTICLE
Chengguo Pang, Ruijiao Wang, Kemeng Liu, Xu Yuan, Jiating Ni, Qingyu Cao, Yuanjin Chen, Pei Liang Dong, Hua Han
The "schisandra-evodia" herb pair (S-E) is a herbal preparation to treat Alzheimer's disease (AD). This study aims to investigate the therapeutic efficacy and potential mechanism of S-E in AD rats, utilizing pharmacodynamic assessments and serum- and urine-based metabolomic analyses. Pharmacodynamic assessments included Morris water maze test, hematoxylin-eosin staining and immunohistochemistry experiments. The results of the study showed that the AD model was successful; the S-E significantly enhanced long-term memory and spatial learning in AD rats...
April 22, 2024: Biomedical Chromatography: BMC
https://read.qxmd.com/read/38649099/modeling-an-evaluation-of-the-efficacy-of-the-novel-neuroanalgesic-drug-mirogabalin-for-diabetic-peripheral-neuropathic-pain-and-postherpetic-neuralgia-therapy
#16
JOURNAL ARTICLE
Li-Mian Hong, Jian-Min Liu, Lei Lin, Chun-Chun Huang, Rui Chen, Wei-Wei Lin
Diabetic peripheral neuropathic pain (DPNP) and postherpetic neuralgia (PHN) are challenging and often intractable complex medical conditions, with a substantial impact on the quality of life. Mirogabalin, a novel voltage-gated Ca2+ channel α2δ ligand, was approved for the indication of DPNP and PHN. However, the time course of effects has not yet been clarified.We aimed to establish pharmacodynamic and placebo effect models of mirogabalin and pregabalin in DPNP and PHN, and to quantitatively compare the efficacy characteristics (maximum efficacy, onset time, and other pharmacodynamic parameters) and safety of mirogabalin and pregabalin...
April 20, 2024: European Journal of Pharmaceutical Sciences
https://read.qxmd.com/read/38646934/pyrimidine-depletion-enhances-targeted-and-immune-therapy-combinations-in-acute-myeloid-leukemia
#17
JOURNAL ARTICLE
Ola A Elgamal, Sydney Fobare, Sandip Vibhute, Abeera Mehmood, Dennis C Vroom, Mariah L Johnson, Blaise Stearns, James R Lerma, Jean Truxall, Emily Stahl, Bridget Carmichael, Shelley J Orwick, Alice S Mims, Emily Curran, Ramasamy Santhanam, Susheela Tridandapani, Mitch A Phelps, Zhiliang Xie, Christopher C Coss, Sharyn D Baker, Jeffrey Patrick, Janel K Ezzell, Jayesh Rai, Jianmin Pan, Shesh N Rai, Cody Stillwell, Mark Wunderlich, Mouad Abdulrahim, Thomas E Goodwin, Gerard Hilinski, Chad E Bennett, Erin Hertlein, John C Byrd
Acute myeloid leukemia (AML) is a fatal disease characterized by the accumulation of undifferentiated myeloblasts, and agents that promote differentiation have been effective in this disease but are not curative. Dihydroorotate dehydrogenase inhibitors (DHODHi) have the ability to promote AML differentiation and target aberrant malignant myelopoiesis. We introduce HOSU-53, a DHODHi with significant monotherapy activity, which is further enhanced when combined with other standard-of-care therapeutics. We further discovered that DHODHi modulated surface expression of CD38 and CD47, prompting the evaluation of HOSU-53 combined with anti-CD38 and anti-CD47 therapies, where we identified a compelling curative potential in an aggressive AML model with CD47 targeting...
April 22, 2024: JCI Insight
https://read.qxmd.com/read/38645004/drug-loaded-nanoparticles-for-cancer-therapy-a-high-throughput-multicellular-agent-based-modeling-study
#18
Yafei Wang, Elmar Bucher, Heber Rocha, Vikram Jadhao, John Metzcar, Randy Heiland, Hermann B Frieboes, Paul Macklin
Interactions between biological systems and nanomaterials have become an important area of study due to the application of nanomaterials in medicine. In particular, the application of nanomaterials for cancer diagnosis or treatment presents a challenging opportunity due to the complex biology of this disease spanning multiple time and spatial scales. A system-level analysis would benefit from mathematical modeling and computational simulation to explore the interactions between anticancer drug-loaded nanoparticles (NPs), cells, and tissues, and the associated parameters driving this system and a patient's overall response...
April 12, 2024: bioRxiv
https://read.qxmd.com/read/38643714/integrated-pharmacokinetic-properties-and-tissue-distribution-of-multiple-active-constituents-in-qing-yi-recipe-a-comparison-between-granules-and-decoction
#19
JOURNAL ARTICLE
Shurong Ma, Tianfu Wei, Biao Zhang, Yunshu Zhang, Jinwen Lai, Jialin Qu, Jianjun Liu, Peiyuan Yin, Dong Shang
BACKGROUND: Qing-Yi Recipe, a classic traditional Chinese medicine (TCM), is widely used for treating acute diseases of the abdomen, especially pancreatitis, the efficacy of which has been demonstrated in more than thirty clinical trials. However, the in-vivo pharmacodynamic material basis for this formula remains unclear. METHODS: A sensitive and accurate method for quantifying twenty-two potential bioactive constituents of Qing-Yi Recipe in biological samples was developed using liquid chromatography-tandem mass spectrometry (LC-MS/MS), and this method was fully validated...
April 15, 2024: Phytomedicine
https://read.qxmd.com/read/38643703/simultaneous-determination-of-five-constituents-of-areca-nut-extract-in-rat-plasma-using-uplc-ms-ms-and-its-application-in-a-pharmacokinetic-study
#20
JOURNAL ARTICLE
Mingyu Pan, Wenfeng Geng, Yuanxiao Wang, Makoto Tsunoda, Jiatong Liu, Yingxia Zhang, Haimei Yang, Lu-Shuang Li, Shiwen Song, Jinqiang Liang, Yanting Song
Areca nuts have been used as a traditional Chinese medicine (TCM) for thousands of years. Recent studies have shown that it exhibits good pharmacological activity and toxicity. In this study, the pharmacokinetics of five major components of areca nut extract in rats were investigated using a highly sensitive ultra-performance liquid chromatography coupled with triple quadrupole mass spectrometry (UPLC-MS/MS) method. Arecoline, arecaidine, guvacoline, guvacine, and catechin were separated and quantified accurately using gradient elution with mobile phases of (A) water containing 0...
April 16, 2024: Journal of Pharmaceutical and Biomedical Analysis
keyword
keyword
6597
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.